Articles

Brugada Syndrome: Defining the Risk in Asymptomatic Patients

Citation:

Arrhythmia & Electrophysiology Review 2016;5(3):164–9

Cardiac Resynchronisation Therapy: The Optimal QRS Duration Revisited

Citation:

Arrhythmia & Electrophysiology Review 2016;5(2):80-1

Arrhythmogenic Cardiomyopathy: Electrical and Structural Phenotypes

Citation:

Arrhythmia & Electrophysiology Review 2016;5(2):90–101

Brugada Syndrome and Early Repolarisation

Citation:

Arrhythmia & Electrophysiology Review2016;5(2):84–9

The European Heart Rhythm Association: A Myriad of Benefits and Privileges

Citation:

Arrhythmia & Electrophysiology Review 2016;5(2):82

Antiarrhythmic Drug Therapy to Avoid ICD Shocks

Citation:

Arrhythmia & Electrophysiology Review 2016;5(2):117–21

Individualising Anticoagulant Therapy in Atrial Fibrillation Patients

Citation:

Arrhythmia & Electrophysiology Review 2016;5(2):102–9

Consensus Document on Supraventricular Arrhythmias: A Valuable Initiative from EHRA

Citation:

Arrhythmia & Electrophysiology Review 2016;5(1):8

The European Heart Rhythm Association: On the Move Towards the Future of Electrophysiology

Citation:

Arrhythmia & Electrophysiology Review 2016;5(1):10-1

Atrioventricular Nodal Reentrant Tachycardia

Citation:

Arrhythmia & Electrophysiology Review 2016;5(2):130–5